Accordingly, in vivo target inhibition (IVTI) confirmed the ability of Pz-1 to reduce phosphorylation of RET and TRKA, and some downstream signalling targets, at the doses used for tumour growth inhibition (Supplementary information, Figure S7). This evidence concerns the gene RET and neoplasm.